Finch Therapeutics Group, Inc. (FNCH)
OTCMKTS · Delayed Price · Currency is USD
13.25
-0.11 (-0.85%)
Feb 25, 2026, 2:47 PM EST

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Biotechnology
107.00K861.00K18.53M7.72M10.15M
Biotechnology Growth
-87.57%-95.35%140.08%-23.98%-
Total
107.00K861.00K18.53M7.72M10.15M
Total Growth
-87.57%-95.35%140.08%-23.98%-

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States
107.00K861.00K18.53M7.72M10.15M
United States Growth
-87.57%-95.35%140.08%-23.98%-
Total
107.00K861.00K18.53M7.72M10.15M
Total Growth
-87.57%-95.35%140.08%-23.98%-
Source: S&P Global Market Intelligence.